Latest filing published 22 Oct 2026 for Anixa Biosciences Inc, €19k.
Based on 32 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Amit Kumar span 2 companies, the busiest being Anixa Biosciences Inc and Ascent Solar Technologies, Inc. The record holds 50 filings, for trades running from 1 January 2016 to 22 October 2026.
In open-market terms, that means 41 purchases worth €1.0M on one side and 1 sale worth €38k on the other. Taken together, the purchases exceed the sales by €964k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants and 3 option exercises. Since January 2026: 11 purchases and no sales on the market.
The median purchase comes to €15k. Relative to company size, the median is 0.016% of market cap (9 purchases with a known value). 26 out of 40 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 32 purchases old enough to measure, the stock rose over the following 90 days in 38% of cases; the median change was -3.3%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 22 October 2026, the filings show an open-market purchase worth €19k in Anixa Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations